Abstract:Background: Neuroimaging reveals structural brain changes linked with HIV infection and related neurocognitive disorders; however, group-level comparisons between people with HIV and people without HIV do not account for within-group heterogeneity. The aim of this study was to quantify the effects of comorbidities such as cardiovascular disease and adverse social determinants of health on brain ageing in people with HIV and people without HIV. Methods: In this retrospective case-control study, people with HIV from Washington University in St Louis, MO, USA, and people without HIV identified through community organisations or the Research Participant Registry were clinically characterised and underwent 3-Tesla T1-weighted MRI between Dec 3, 2008, and Oct 4, 2022. Exclusion criteria were established by a combination of self-reports and medical records. DeepBrainNet, a publicly available machine learning algorithm, was applied to estimate brain-predicted age from MRI for people with HIV and people without HIV. The brain-age gap, defined as the difference between brain-predicted age and true chronological age, was modelled as a function of clinical, comorbid, and social factors by use of linear regression. Variables were first examined singly for associations with brain-age gap, then combined into multivariate models with best-subsets variable selection. Findings: In people with HIV (mean age 44·8 years [SD 15·5]; 78% [296 of 379] male; 69% [260] Black; 78% [295] undetectable viral load), brain-age gap was associated with Framingham cardiovascular risk score (p=0·0034), detectable viral load (>50 copies per mL; p=0·0023), and hepatitis C co-infection (p=0·0065). After variable selection, the final model for people with HIV retained Framingham score, hepatitis C, and added unemployment (p=0·0015). Educational achievement assayed by reading proficiency was linked with reduced brain-age gap (p=0·016) for people without HIV but not for people with HIV, indicating a potential resilience factor. When people with HIV and people without HIV were modelled jointly, selection resulted in a model containing cardiovascular risk (p=0·0039), hepatitis C (p=0·037), Area Deprivation Index (p=0·033), and unemployment (p=0·00010). Male sex (p=0·078) and alcohol use history (p=0·090) were also included in the model but were not individually significant. Interpretation: Our findings indicate that comorbid and social determinants of health are associated with brain ageing in people with HIV, alongside traditional HIV metrics such as viral load and CD4 cell count, suggesting the need for a broadened clinical perspective on healthy ageing with HIV, with additional focus on comorbidities, lifestyle changes, and social factors. Funding: National Institute of Mental Health, National Institute of Nursing Research, and National Institute of Drug Abuse.

Recent advances in HIV-associated neurocognitive disorders: a focus on older adults and sub-Saharan Africa

Multimodal Approach to Neurocognitive Function in People Living with HIV in the cART Era: A Comprehensive Review

Emerging directions of cognitive aging with HIV: practice and policy implications for social work

Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm

Updated research nosology for HIV-associated neurocognitive disorders

Neuropsychological tests associated with symptomatic HIV-associated neurocognitive disorder (HAND) in a cohort of older adults in Tanzania

HIV-related neurocognitive disorders: Diagnosis, Treatment, and Mental Health Implications: A Review

Future Directions for Diagnosis and Treatment

The impact of aging on HIV-1-related neurocognitive impairment

Neuropathologic Findings in Elderly HIV-Positive Individuals

Neuropsychological Characteristics of Adults with HIV: A Systematic Review

Interaction Effects between HIV and Aging on Selective Neurocognitive Impairment

Prevalence and associated factors of neurocognitive disorder among people living with HIV/AIDS in the South Gondar zone primary hospitals, North-West Ethiopia: an institution-based cross-sectional study

Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review

Cognitive impairment and neurocognitive profiles among people living with HIV and HIV-negative individuals older over 50 years: a comparison of IHDS, MMSE and MoCA

Cerebral abnormalities in HIV-infected individuals with neurocognitive impairment revealed by fMRI

Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders

[A Systematic Review on Blood Biomarkers of Neurocognitive Disorders in HIV Infected Individuals].

Effects of clinical, comorbid, and social determinants of health on brain ageing in people with and without HIV: a retrospective case-control study

The magnitude of neurocognitive disorders and associated factors among people living with HIV AIDS facilities in Bahir Dar City Ethiopia

Cerebral regional and network abnormalities in HIV-infected with neurocognitive impairments: An fMRI study